• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NasdaqGM
    8.65 Up 0.13(1.53%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:8.52
    Open:8.52
    Bid:8.65 x 3400
    Ask:8.66 x 4200
    1y Target Est:12.25
    Beta:1.53
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:8.45 - 8.66
    52wk Range:7.09 - 11.47
    Volume:173,574
    Avg Vol (3m):404,424
    Market Cap:371.34M
    P/E (ttm):N/A
    EPS (ttm):-0.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SUPNUp 1.53%371.34M
    JNJUp 0.45%294.07B

    Key Statistics

    Forward P/E (1 yr):20.12
    P/S (ttm):3.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.01
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback